By Matthew Carr It’s hard to believe there are only a handful of hours left in 2019.
And what a year it’s been!
Over the past several weeks, my focus has been on helping investors position themselves for the biggest possible gains in 2020.
And we’re seeing this pay off.
In mid-November, I wrote about 10 small caps expected to see revenue grow at least 100% in 2020. Even though Sage Therapeutics (Nasdaq: SAGE) has buckled and Tellurian (Nasdaq: TELL) has slipped since then, the rest have gained…
In fact, GSX Techedu (NYSE: GSX) has broken out, surging 50% and setting new 52-week highs!
But those aren’t the only …read more
